Centauri Therapeutics raises €6.9M Series A round
24 February 2026· Nether Alderley, United Kingdom· health, biotech, b2b, b2g, deep_hardware
The investment will support the completion of Phase I clinical studies for CTX-187, the company's lead clinical candidate in the ABX-01 programme, and expand the scope of additional research activities in preparation for Phase II.
“We are extremely pleased to welcome the AMR Action Fund as a new investor. Their dedication to advancing the field of antimicrobials further reinforces our belief in the Alphamer platform as a transformative immunotherapeutic approach for addressing infections. This latest investment has enabled us a clear path to progress CTX-187 beyond Phase I trials and onto the development of a Phase II-ready asset.”
Investors
LeadAMR Action Fund
About Centauri Therapeutics
Headquarters
Nether Alderley, United Kingdom
Founded
2014
Team Size
21–50
Sectors
healthbiotechb2bb2gdeep_hardware
Source: https://www.finsmes.com/2026/02/centauri-therapeutics-raises-6m-in-series-a-extension-funding.html